95 related articles for article (PubMed ID: 19854223)
21. Correlative studies support lipid peroxidation is linked to PrP(res) propagation as an early primary pathogenic event in prion disease.
Brazier MW; Lewis V; Ciccotosto GD; Klug GM; Lawson VA; Cappai R; Ironside JW; Masters CL; Hill AF; White AR; Collins S
Brain Res Bull; 2006 Jan; 68(5):346-54. PubMed ID: 16377442
[TBL] [Abstract][Full Text] [Related]
22. Removal of exogenous (spiked) and endogenous prion infectivity from red cells with a new prototype of leukoreduction filter.
Sowemimo-Coker S; Kascsak R; Kim A; Andrade F; Pesci S; Kascsak R; Meeker C; Carp R; Brown P
Transfusion; 2005 Dec; 45(12):1839-44. PubMed ID: 16371036
[TBL] [Abstract][Full Text] [Related]
23. Molecular biology and transgenetics of prion diseases.
Prusiner SB
Crit Rev Biochem Mol Biol; 1991; 26(5-6):397-438. PubMed ID: 1684745
[TBL] [Abstract][Full Text] [Related]
24. A novel copper-hydrogen peroxide formulation for prion decontamination.
Solassol J; Pastore M; Crozet C; Perrier V; Lehmann S
J Infect Dis; 2006 Sep; 194(6):865-9. PubMed ID: 16941355
[TBL] [Abstract][Full Text] [Related]
25. Prion protein adsorption to soil in a competitive matrix is slow and reduced.
Saunders SE; Bartz JC; Bartelt-Hunt SL
Environ Sci Technol; 2009 Oct; 43(20):7728-33. PubMed ID: 19921886
[TBL] [Abstract][Full Text] [Related]
26. Pall leukotrap affinity prion-reduction filter removes exogenous infectious prions and endogenous infectivity from red cell concentrates.
Sowemimo-Coker SO; Pesci S; Andrade F; Kim A; Kascsak RB; Kascsak RJ; Meeker C; Carp R
Vox Sang; 2006 May; 90(4):265-75. PubMed ID: 16635068
[TBL] [Abstract][Full Text] [Related]
27. The reconstitution of mammalian prion infectivity de novo.
Baskakov IV
FEBS J; 2007 Feb; 274(3):576-87. PubMed ID: 17288547
[TBL] [Abstract][Full Text] [Related]
28. Prion encephalopathies of animals and humans.
Prusiner SB
Dev Biol Stand; 1993; 80():31-44. PubMed ID: 8270114
[TBL] [Abstract][Full Text] [Related]
29. A rapid dual staining procedure for the quantitative discrimination of prion amyloid from tissues reveals how interactions between amyloid and lipids in tissue homogenates may hinder the detection of prions.
Hervé R; Collin R; Pinchin HE; Secker T; Keevil CW
J Microbiol Methods; 2009 Apr; 77(1):90-7. PubMed ID: 19318058
[TBL] [Abstract][Full Text] [Related]
30. Detection of prion after decontamination procedures: comparative study of standard Western blot, filter retention and scrapie-cell assay.
Solassol J; Arlotto M; Lehmann S
J Hosp Infect; 2004 Jun; 57(2):156-61. PubMed ID: 15183247
[TBL] [Abstract][Full Text] [Related]
31. An improved Western blot assay to assess the clearance of prion protein from plasma-derived therapeutic proteins.
Hartwell RC; Nelson MS; Kislan MM; Stenland CJ; Miller JL; Pifat DY; Petteway SR; Cai K
J Virol Methods; 2005 May; 125(2):187-93. PubMed ID: 15794989
[TBL] [Abstract][Full Text] [Related]
32. Infectious prion protein in the filtrate even after 15 nm filtration.
Yunoki M; Tanaka H; Urayama T; Kanai Y; Nishida A; Yoshikawa M; Ohkubo Y; Kawabata Y; Hagiwara K; Ikuta K
Biologicals; 2010 Mar; 38(2):311-3. PubMed ID: 19931469
[TBL] [Abstract][Full Text] [Related]
33. Comparison of nanofiltration efficacy in reducing infectivity of centrifuged versus ultracentrifuged 263K scrapie-infected brain homogenates in "spiked" albumin solutions.
Cardone F; Simoneau S; Arzel A; Puopolo M; Berardi VA; Abdel-Haq H; Galeno R; De Pascalis A; Sbriccoli M; Graziano S; Valanzano A; Porte P; Diringer H; Brown P; Flan B; Pocchiari M
Transfusion; 2012 May; 52(5):953-62. PubMed ID: 22082124
[TBL] [Abstract][Full Text] [Related]
34. The welfare problems associated with using transgenic mice to bioassay for bovine spongiform encephalopathy.
Jenkins ES; Combes RD
Anim Welf; 1999; 8(4):421-31. PubMed ID: 11933934
[TBL] [Abstract][Full Text] [Related]
35. Partitioning of TSE infectivity during ethanol fractionation of human plasma.
Gregori L; Maring JA; MacAuley C; Dunston B; Rentsch M; Kempf C; Rohwer RG
Biologicals; 2004 Mar; 32(1):1-10. PubMed ID: 15026020
[TBL] [Abstract][Full Text] [Related]
36. Sensitive detection of pathological prion protein by cyclic amplification of protein misfolding.
Saborio GP; Permanne B; Soto C
Nature; 2001 Jun; 411(6839):810-3. PubMed ID: 11459061
[TBL] [Abstract][Full Text] [Related]
37. Investigations of prion and virus safety of a new liquid IVIG product.
Stucki M; Boschetti N; Schäfer W; Hostettler T; Käsermann F; Nowak T; Gröner A; Kempf C
Biologicals; 2008 Jul; 36(4):239-47. PubMed ID: 18337119
[TBL] [Abstract][Full Text] [Related]
38. Prion removal effect of a specific affinity ligand introduced into the manufacturing process of the pharmaceutical quality solvent/detergent (S/D)-treated plasma OctaplasLG.
Neisser-Svae A; Bailey A; Gregori L; Heger A; Jordan S; Behizad M; Reichl H; Römisch J; Svae TE
Vox Sang; 2009 Oct; 97(3):226-33. PubMed ID: 19548963
[TBL] [Abstract][Full Text] [Related]
39. Ultra-sensitive detection of prion protein fibrils by flow cytometry in blood from cattle affected with bovine spongiform encephalopathy.
Trieschmann L; Navarrete Santos A; Kaschig K; Torkler S; Maas E; Schätzl H; Böhm G
BMC Biotechnol; 2005 Oct; 5():26. PubMed ID: 16202155
[TBL] [Abstract][Full Text] [Related]
40. Biological and biochemical characteristics of prion strains conserved in persistently infected cell cultures.
Arima K; Nishida N; Sakaguchi S; Shigematsu K; Atarashi R; Yamaguchi N; Yoshikawa D; Yoon J; Watanabe K; Kobayashi N; Mouillet-Richard S; Lehmann S; Katamine S
J Virol; 2005 Jun; 79(11):7104-12. PubMed ID: 15890950
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
